MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: MMS_Medical_Surgical Training & Simulation
Osso VR
Industry: Silicon Valley, California
Jasper Therapeutics, Inc. (NASDAQ: JSPR)*
Organization & Developments: Jasper Therapeutics
Parents
Jasper Therapeutics, Inc. (NASDAQ: JSPR)*
Children
*Biotechnology company focused on hematopoietic cell transplant therapies
*Jasper has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent that clears hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation
2024: Jasper dials up dose after complete responses come and go quickly in hives trial
2024: Jasper Posts Promising Mid-Stage Data for Urticaria Drug, Eyes Challenge to Blockbusters
2024: Jasper Therapeutics Reports Positive Data from SPOTLIGHT
2024: Jasper Therapeutics: Briquilimab's Potential In Chronic Urticaria And Asthma
Jumps
Finance & Acquisitions: Jasper Therapeutics
Key People: Jasper Therapeutics